San Diego, CA, United States of America

Suk Joong Lee

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: The Innovations of Suk Joong Lee

Introduction

Suk Joong Lee is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of medicinal chemistry. With a total of six patents to his name, he has made remarkable strides in developing compounds that target critical enzymes involved in various diseases.

Latest Patents

Among his latest patents are the pyrimidine and pyridine amine compounds, which serve as enzyme p70S6K inhibitors. These compounds are particularly useful in treating S6K-dependent or S6K-mediated diseases and conditions, including cancer, fibrotic metabolic disorders, and certain neurological disorders. The innovative nature of these compounds highlights Suk Joong Lee's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Suk Joong Lee has worked with notable organizations, including Lawrence Livermore National Security, LLC and Merck Sharp & Dohme Corporation. His experience in these esteemed companies has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Suk Joong Lee has collaborated with talented individuals such as Daniel Bensen and Zhiyong Chen, who have played significant roles in his research endeavors. Their combined efforts have further propelled the development of innovative solutions in the field of disease treatment.

Conclusion

Suk Joong Lee's work exemplifies the impact of innovation in medicine, particularly through his patented compounds that target critical enzymes. His contributions continue to pave the way for advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…